Sohag university hospitals,sohag ,sohag
Sohag, Egypt
NCT Number: NCT07350772
Atypical presentations of SLE including unusual initial symptoms, predominant organ involvement, late-onset disease and ANA-negative remain poorly characterized. These forms are often associated with delayed diagnosis and potentially worse clinical outcomes. Most existing studies focus on isolated rare manifestations rather than analyzing atypical SLE as a cohesive category. Understanding these differences is crucial and this study aims to compare atypical and typical SLE presentations to clarify variations in prognosis, treatment requirements and subsequent organ involvement.
Trial opening soon.
Get Notified19 year and older
All sexes
Observational
Sohag, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients diagnosed as SLE according toSLICC 2012Classification Criteria[13] :
A. Patients presented with typical lupus presentation:
B. Patients presented with atypical lupus presentation:
Exclusion criteria
Exclusion criteria
-
Time frame: Baseline (0 month), 6 months, 12 months
SLEDAI-2K score will be calculated for each participant. Data will be reported as mean ± SD and compared between patients with typical and atypical SLE presentations
Time frame: 6 months, 12 months
Systemic Lupus International Collaborating Clinics Damage Index (SDI) will be assessed to evaluate irreversible organ damage. Data will be reported as mean ± SD and compared between patients with typical and atypical SLE presentations
Contact information is provided by the study sponsor or research team.
Ahmed Mohamed Mahrous, professor
CONTACT
Yasmine Fatah Mohamed, MD
CONTACT
01032071095 ext. 01106191664
Sohag University
Other
Atypical Lupus Presentations and Their Prognostic Implications
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729826
Autoimmune Diseases, Connective Tissue Diseases
View Trial DetailsNCT07680010
Autoimmune Diseases, Blood Coagulation Disorders
Bordeaux, France
View Trial DetailsNCT07555626
Autoimmune Diseases, Connective Tissue Diseases
Kayseri, Melikgazi, Turkey (Türkiye)
View Trial DetailsNCT07544225
Arthritis, Arthritis, Rheumatoid
Villejuif, Val de Marne, France
View Trial Details